Logo image of CMPO

COMPOSECURE INC-A (CMPO) Stock Fundamental Analysis

USA - NASDAQ:CMPO - US20459V1052 - Common Stock

19.52 USD
+0.08 (+0.41%)
Last: 9/15/2025, 8:00:00 PM
19.52 USD
0 (0%)
After Hours: 9/15/2025, 8:00:00 PM
Fundamental Rating

4

Overall CMPO gets a fundamental rating of 4 out of 10. We evaluated CMPO against 33 industry peers in the Technology Hardware, Storage & Peripherals industry. Both the profitability and the financial health of CMPO get a neutral evaluation. Nothing too spectacular is happening here. CMPO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year CMPO was profitable.
CMPO had a positive operating cash flow in the past year.
In multiple years CMPO reported negative net income over the last 5 years.
CMPO had a positive operating cash flow in 4 of the past 5 years.
CMPO Yearly Net Income VS EBIT VS OCF VS FCFCMPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

CMPO has a Return On Assets of -26.48%. This is in the lower half of the industry: CMPO underperforms 72.73% of its industry peers.
CMPO has a better Return On Invested Capital (14.31%) than 78.79% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CMPO is significantly above the industry average of 14.98%.
The last Return On Invested Capital (14.31%) for CMPO is well below the 3 year average (52.37%), which needs to be investigated, but indicates that CMPO had better years and this may not be a problem.
Industry RankSector Rank
ROA -26.48%
ROE N/A
ROIC 14.31%
ROA(3y)3.24%
ROA(5y)3.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
CMPO Yearly ROA, ROE, ROICCMPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

The Operating Margin of CMPO (17.95%) is better than 84.85% of its industry peers.
In the last couple of years the Operating Margin of CMPO has declined.
Looking at the Gross Margin, with a value of 51.04%, CMPO belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
In the last couple of years the Gross Margin of CMPO has remained more or less at the same level.
Industry RankSector Rank
OM 17.95%
PM (TTM) N/A
GM 51.04%
OM growth 3Y-5.56%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.2%
GM growth 5YN/A
CMPO Yearly Profit, Operating, Gross MarginsCMPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CMPO is creating value.
Compared to 1 year ago, CMPO has more shares outstanding
Compared to 1 year ago, CMPO has an improved debt to assets ratio.
CMPO Yearly Shares OutstandingCMPO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CMPO Yearly Total Debt VS Total AssetsCMPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.58 indicates that CMPO is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CMPO (2.58) is better than 60.61% of its industry peers.
CMPO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0
Altman-Z 2.58
ROIC/WACC1.7
WACC8.4%
CMPO Yearly LT Debt VS Equity VS FCFCMPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M -200M -400M -600M -800M -1B

2.3 Liquidity

CMPO has a Current Ratio of 0.11. This is a bad value and indicates that CMPO is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CMPO (0.11) is worse than 96.97% of its industry peers.
CMPO has a Quick Ratio of 0.11. This is a bad value and indicates that CMPO is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CMPO (0.11) is worse than 96.97% of its industry peers.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11
CMPO Yearly Current Assets VS Current LiabilitesCMPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

CMPO shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.90%.
The Revenue for CMPO has decreased by -47.83% in the past year. This is quite bad
The Revenue has been growing by 16.22% on average over the past years. This is quite good.
EPS 1Y (TTM)-4.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.41%
Revenue 1Y (TTM)-47.83%
Revenue growth 3Y16.22%
Revenue growth 5YN/A
Sales Q2Q%10.16%

3.2 Future

The Earnings Per Share is expected to grow by 0.32% on average over the next years.
The Revenue is expected to grow by 7.82% on average over the next years.
EPS Next Y4%
EPS Next 2Y5.75%
EPS Next 3Y0.32%
EPS Next 5YN/A
Revenue Next Year7.78%
Revenue Next 2Y7.95%
Revenue Next 3Y7.82%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CMPO Yearly Revenue VS EstimatesCMPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CMPO Yearly EPS VS EstimatesCMPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.12, which indicates a rather expensive current valuation of CMPO.
CMPO's Price/Earnings ratio is a bit cheaper when compared to the industry. CMPO is cheaper than 75.76% of the companies in the same industry.
When comparing the Price/Earnings ratio of CMPO to the average of the S&P500 Index (27.27), we can say CMPO is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 17.63, the valuation of CMPO can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CMPO is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.77, CMPO is valued a bit cheaper.
Industry RankSector Rank
PE 20.12
Fwd PE 17.63
CMPO Price Earnings VS Forward Price EarningsCMPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CMPO's Enterprise Value to EBITDA is on the same level as the industry average.
CMPO's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CMPO is cheaper than 60.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.6
EV/EBITDA 36.58
CMPO Per share dataCMPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.03
PEG (5Y)N/A
EPS Next 2Y5.75%
EPS Next 3Y0.32%

More info and screens

0

5. Dividend

5.1 Amount

CMPO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COMPOSECURE INC-A

NASDAQ:CMPO (9/15/2025, 8:00:00 PM)

After market: 19.52 0 (0%)

19.52

+0.08 (+0.41%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners60.15%
Inst Owner Change8.48%
Ins Owners7.62%
Ins Owner Change-0.14%
Market Cap2.00B
Analysts78.33
Price Target19.99 (2.41%)
Short Float %28.19%
Short Ratio12.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.66%
Min EPS beat(2)16.71%
Max EPS beat(2)28.61%
EPS beat(4)2
Avg EPS beat(4)7.68%
Min EPS beat(4)-7.35%
Max EPS beat(4)28.61%
EPS beat(8)4
Avg EPS beat(8)5.46%
EPS beat(12)4
Avg EPS beat(12)1.81%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.36%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)6.02%
Revenue beat(4)1
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)6.02%
Revenue beat(8)4
Avg Revenue beat(8)0.19%
Revenue beat(12)5
Avg Revenue beat(12)-0.23%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)25.64%
PT rev (3m)28.83%
EPS NQ rev (1m)0.75%
EPS NQ rev (3m)-7.16%
EPS NY rev (1m)7.96%
EPS NY rev (3m)8.79%
Revenue NQ rev (1m)0.47%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)2.34%
Revenue NY rev (3m)2.59%
Valuation
Industry RankSector Rank
PE 20.12
Fwd PE 17.63
P/S 7.46
P/FCF 32.6
P/OCF 30.01
P/B N/A
P/tB N/A
EV/EBITDA 36.58
EPS(TTM)0.97
EY4.97%
EPS(NY)1.11
Fwd EY5.67%
FCF(TTM)0.6
FCFY3.07%
OCF(TTM)0.65
OCFY3.33%
SpS2.62
BVpS-1.04
TBVpS-1.04
PEG (NY)5.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.48%
ROE N/A
ROCE 18.11%
ROIC 14.31%
ROICexc 14.57%
ROICexgc 14.57%
OM 17.95%
PM (TTM) N/A
GM 51.04%
FCFM 22.89%
ROA(3y)3.24%
ROA(5y)3.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
ROICexc(3y)64.23%
ROICexc(5y)N/A
ROICexgc(3y)64.23%
ROICexgc(5y)N/A
ROCE(3y)66.3%
ROCE(5y)N/A
ROICexcg growth 3Y-41.29%
ROICexcg growth 5YN/A
ROICexc growth 3Y-41.29%
ROICexc growth 5YN/A
OM growth 3Y-5.56%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.2%
GM growth 5YN/A
F-Score3
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 85.62%
Cap/Sales 1.98%
Interest Coverage 4.87
Cash Conversion 122.7%
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z 2.58
F-Score3
WACC8.4%
ROIC/WACC1.7
Cap/Depr(3y)109.34%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.4%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.41%
EPS Next Y4%
EPS Next 2Y5.75%
EPS Next 3Y0.32%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.83%
Revenue growth 3Y16.22%
Revenue growth 5YN/A
Sales Q2Q%10.16%
Revenue Next Year7.78%
Revenue Next 2Y7.95%
Revenue Next 3Y7.82%
Revenue Next 5YN/A
EBIT growth 1Y-68.65%
EBIT growth 3Y9.76%
EBIT growth 5YN/A
EBIT Next Year22.22%
EBIT Next 3Y13.8%
EBIT Next 5YN/A
FCF growth 1Y-26.26%
FCF growth 3Y18.37%
FCF growth 5YN/A
OCF growth 1Y-29.43%
OCF growth 3Y18.54%
OCF growth 5YN/A